Literature DB >> 12537213

Smooth muscle cell hypertrophy of renal cortex arteries with chronic continuous flow left ventricular assist.

Shin'ichiro Kihara1, Kenneth N Litwak, Larry Nichols, Philip Litwak, Marina V Kameneva, Zhongjun Wu, Robert L Kormos, Bartley P Griffith.   

Abstract

BACKGROUND: Pathophysiology of long-term continuous flow left ventricular assist is not well described. With many of these devices becoming available, it is important to examine for possible pathologic effects. In this study we examined the relationship between diminished pulsatility and pathologic changes in renal cortical arteries.
METHODS: Twenty-nine calves were implanted with various continuous flow left ventricular assist systems in a left ventricle-descending thoracic aorta bypass configuration. Pulsatility was quantified by pulse pressure and pulsatility index. Pathologic changes of the renal cortex arteries were described and evaluated by medial thickness, medial/vascular cross-sectional area ratio, and smooth muscle cell count, to quantify hypertrophy or hyperplasia. Seven calves, which underwent a sham-implant, were used as controls.
RESULTS: Systolic arterial pressure, pulse pressure, and pulsatility index were significantly lower and diastolic pressure was significantly higher than before implant in pump-implanted animals. Twenty-three of 29 pumpimplanted calves (79.3%) had medial smooth muscle cell hypertrophy in renal cortex arteries, whereas none of sham-implanted calves had any abnormal lesions. When the pump-implanted calves were grouped according to the presence of smooth muscle cell hypertrophy, there was a clear trend toward lower pump flow rate in calves with lesions. Renal function was within the normal range in all calves.
CONCLUSIONS: There appears to be a relationship between smooth muscle cell hypertrophy in renal cortex arteries and continuous flow left ventricular assist. Furthermore, although the pathologic changes are likely multifactorial, these lesions appear to be related to lower pump assist rates.

Entities:  

Mesh:

Year:  2003        PMID: 12537213     DOI: 10.1016/s0003-4975(02)04087-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Letter to the Editor regarding the article "Left ventricular assist devices: a kidney's perspective".

Authors:  Timothy K Cooper
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

2.  Absence of structural lesions in human renal arcuate arteries after LVAD implantation: response to a letter regarding "left ventricular assist devices: a kidney's perspective".

Authors:  Tycho R Tromp; Tri Q Nguyen; Nicolaas de Jonge; Jaap A Joles
Journal:  Heart Fail Rev       Date:  2015-11       Impact factor: 4.214

Review 3.  Chronic nonpulsatile blood flow is compatible with normal end-organ function: implications for LVAD development.

Authors:  Satoshi Saito; Tomohiro Nishinaka
Journal:  J Artif Organs       Date:  2005       Impact factor: 1.731

Review 4.  Kidney dysfunction and left ventricular assist device support: a comprehensive perioperative review.

Authors:  Samuel T Coffin; Dia R Waguespack; Nicholas A Haglund; Simon Maltais; Jamie P Dwyer; Mary E Keebler
Journal:  Cardiorenal Med       Date:  2015-01-09       Impact factor: 2.041

5.  Nonphysiologic blood flow triggers endothelial and arterial remodeling in vivo: implications for novel left ventricular assist devices with a peripheral anastomosis.

Authors:  Carlo R Bartoli; Paul A Spence; Thorsten Siess; Daniel H Raess; Steven C Koenig; Robert D Dowling
Journal:  J Thorac Cardiovasc Surg       Date:  2013-12-09       Impact factor: 5.209

6.  Coronary Artery Remodeling and Fibrosis With Continuous-Flow Left Ventricular Assist Device Support.

Authors:  Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

7.  Prevalence and prognostic importance of changes in renal function after mechanical circulatory support.

Authors:  Meredith A Brisco; Stephen E Kimmel; Steven G Coca; Mary E Putt; Mariell Jessup; Wilson W H Tang; Chirag R Parikh; Jeffrey M Testani
Journal:  Circ Heart Fail       Date:  2013-11-08       Impact factor: 8.790

8.  Pre-clinical Implants of the Levitronix PediVAS® Pediatric Ventricular Assist Device - Strategy for Regulatory Approval.

Authors:  Timothy M Maul; Ergin Kocyildirim; John D Marks; Shawn G Bengston; Salim E Olia; Patrick M Callahan; Marina V Kameneva; Stephen Franklin; Harvey S Borovetz; Kurt A Dasse; Peter D Wearden
Journal:  Cardiovasc Eng Technol       Date:  2011-10-27       Impact factor: 2.495

9.  Living Without a Pulse: The Vascular Implications of Continuous-Flow Left Ventricular Assist Devices.

Authors:  Suneet N Purohit; William K Cornwell; Jay D Pal; JoAnn Lindenfeld; Amrut V Ambardekar
Journal:  Circ Heart Fail       Date:  2018-06       Impact factor: 8.790

10.  Reduced pulsatility induces periarteritis in kidney: role of the local renin-angiotensin system.

Authors:  Chiyo Ootaki; Michifumi Yamashita; Yoshio Ootaki; Keiji Kamohara; Stephan Weber; Ryan S Klatte; William A Smith; Alex L Massiello; Steven N Emancipator; Leonard A R Golding; Kiyotaka Fukamachi
Journal:  J Thorac Cardiovasc Surg       Date:  2008-05-19       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.